Phillip R Selby

7PUBLICATIONS
15CO-AUTHORS
Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 01, 2026
Infection risk in myelodysplastic syndromes is dynamic and immune driven.

|Apr 30, 2026
Evaluation of Current and Novel Dosing Strategies for Anti-Thymocyte Globulin in Adult Allogeneic Hematopoietic Stem Cell Transplantation.

|Jun 28, 2024
Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients.

Sherilyn Wong, Philip R Selby, Stephanie E Reuter

|Jan 13, 2024
Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patients.

Philip R Selby, Aaron J Heffernan, David Yeung

|Feb 23, 2023
Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients.

Philip R Selby, Aaron J Heffernan, David Yeung

|Nov 09, 2022
Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches.

Philip R Selby, Morgyn S Warner, Sandra L Peake

Pageof 2

Frequent Collaborators

2 joint publications

Aaron J Heffernan

2 joint publications

Jason A Roberts

2 joint publications

Stephanie E Reuter

1 joint publications

Sherilyn Wong